• Accessibility statement
  • Homepage
  • Sitemap
  • Search
  • Contact
  • Print
Boehringer-Ingelheim Logo
Bedford Laboratories - Beyond Above-And-Beyond™

Meta navigation

jump to main navigationjump to content
  • Home
  • Contact
  • Site Map

Main navigation

jump to contentjump to meta navigation
  • Our Products
  • Sales and Support
  • Our Company
  • Learning Center
  • News & Events
    • News
    • Events & Webinars
    • Media Inquiries
  • Home
  • News & Events

Page content

jump to main navigationjump to meta navigation

Bedford Laboratories News Center

Recent News

12.23.2011 Update on Ben Venue Manufacturing Suspension, the manufacturer of Bedford Laboratories’ Products
11.19.2011 Ben Venue Laboratories, Inc., the manufacturer of Bedford Laboratories’ Products Temporarily Suspends Manufacturing and Distribution of Drug Products
04.12.2011 Bedford Laboratories begins shipping Topotecan Hydrochloride for Injection, 4 mg Single Dose Vial
07.12.2010 Bedford Laboratories to begin shipping Dactinomycin for Injection USP 500 mcg (0.5 mg)
02.16.2010 Bedford Laboratories First to Manufacture FDA Approved Indomethacin for Injection USP
news archive

Upcoming Event

Date Event Additional Information
February 29-March 2, 2012

MHA Business Summit

Booth # 433

ARIA CityCenter, Las Vegas, NV
Back to top

Media Contact

  • Jason Kurtz

    Associate Director, Communications & Public Relations

    • Phone: 1-800-562-4797 x33668
    • E-mail:

RSS Feed

RSS feeds allow you to receive latest news and information about Bedford Labooratories.

subscribe to RSS feed
© 2012 Boehringer Ingelheim All rights reserved
  • Print page
  • Recommend
  • Privacy Policy
  • Terms of use
  • RSS Feed